Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wearable Sensing is a private neurotechnology and medical device company that develops commercial dry-electrode EEG and multimodal physiological sensing systems for research, brain-computer interface, neurofeedback, neuroergonomics, and health-related applications. Its core offering is the Dry Sensor Interface (DSI) platform, which includes wireless dry EEG headsets, hybrid EEG+fNIRS systems, multimodal sensors, and supporting software for synchronized acquisition and analysis. The company emphasizes rapid setup, mobility, comfort, and resistance to motion and electrical artifacts, enabling use in ambulatory, virtual reality, and real-world settings. Wearable Sensing also offers custom development services and distributes its products globally through a network spanning more than 40 countries. In addition to hardware, it markets QStates, a machine-learning-based cognitive state assessment tool built on qEEG, HRV, GSR, and related signals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wearable Sensing.